These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38773000)

  • 1. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity.
    Miyamoto S; Niizato D; Tomomasa D; Nishimura A; Hoshino A; Kamiya T; Isoda T; Takagi M; Kajiwara M; Azumi S; Hirabayashi S; Sakamoto K; Kishimoto K; Miyamura T; Umeda K; Hirose A; Keino D; Yanagimachi M; Kanda K; Sakai Y; Ikawa Y; Watanabe K; Tanaka K; Mori T; Ichinohe T; Sakaguchi H; Morio T; Kanegane H
    J Clin Immunol; 2024 May; 44(6):126. PubMed ID: 38773000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China.
    Gong S; Tian X; Yang R; Yang L; Wang Z; Yang K; Chen K; He X; Deng W; Yang X; Lei M; Fu B
    Transplant Cell Ther; 2024 Dec; 30(12):1213.e1-1213.e12. PubMed ID: 39236789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
    Grunwald MR; Sha W; He J; Sanikommu S; Gerber JM; Ai J; Knight TG; Fasan O; Boseman V; Kaizen W; Chojecki A; Ragon BK; Symanowski J; Avalos B; Copelan E; Ghosh N
    Transplant Cell Ther; 2024 Dec; 30(12):1211.e1-1211.e11. PubMed ID: 39332808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Kiene S; Albrecht M; Theurich S; Scheid C; Skoetz N; Holtick U
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD010189. PubMed ID: 39508306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
    Radford M; Garcia-Horton A; Badami R; Jin E; Usmani N; Grafodatskaya D; McCready E; Khalaf D; Walker I; Leber B; Lepic K; Pond G; Berg T
    Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39547311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease.
    Saib I; Alahmari B; Alsadi H; Alaskar A; Hejazi A; Salama H; Al Raiza A; Saleh ASA; Ibrahim A; Bakkar M; Ghori A; Alsuhaibani A; Alharbi A; Alanazi T; Ahmed R; Shehabeddine I; Alkhraisat S; Alharbi A; Mahasneh I; Ballili M; Aljubour Z; Ahmed M; Alzahrani M
    Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39522720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.
    LeBlanc R; Thiant S; Terra R; Ahmad I; Claveau JS; Bambace N; Bernard L; Cohen S; Delisle JS; Lachance S; Kiss T; Roy DC; Sauvageau G; Roy J
    Curr Oncol; 2024 Nov; 31(11):7258-7274. PubMed ID: 39590165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan.
    Tomomasa D; Suzuki T; Takeuchi I; Goto K; Hagiwara SI; Keino D; Saida S; Ishige T; Kudo T; Eguchi K; Ishimura M; Matsuda Y; Wada T; Ito Y; Kato M; Sasahara Y; Morio T; Arai K; Uhlig HH; Kanegane H
    J Clin Immunol; 2024 Sep; 45(1):6. PubMed ID: 39264505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives in newborn screening for SCID in Japan. Case report: newborn screening identified X-linked severe combined immunodeficiency with a novel
    Beppu S; Nishikawa T; Tomomasa D; Hijikata A; Kasabata H; Terazono H; Ikawa K; Nakamura T; Horikawa S; Nagahama J; Nakamura A; Abematsu T; Nakagawa S; Oketani K; Kanegane H; Okamoto Y
    Front Immunol; 2024; 15():1478411. PubMed ID: 39635533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Resource Utilization and Associated Costs in Patients With Chronic Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation in England.
    Avenoso D; Davidson JA; Larvin H; Brewer HR; Rice CT; Ecsy K; Sil A; Skinner L; Hudson RDA
    Transplant Cell Ther; 2024 Dec; 30(12):1207.e1-1207.e11. PubMed ID: 39389467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
    MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Benfield M; He J; Arnall J; Kaizen W; Jandrisevits E; Eboli-Lopes K; Dodd B; Grunwald MR; Avalos B; Copelan E; Patel JN
    Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39505211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification].
    Wang H; Ma RZ; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):445-452. PubMed ID: 38964918
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study.
    Berghuis D; Mehyar LS; Abu-Arja R; Albert MH; Barnum JL; von Bernuth H; Elfeky R; Lewalle P; Laberko A; Ghosh S; Slatter MA; Weemaes CMR; Yesilipek A; Sirait T; Neven B; Gennery AR; Lankester AC;
    J Clin Immunol; 2024 Aug; 44(8):182. PubMed ID: 39167297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.
    Tramacere I; Virgili G; Perduca V; Lucenteforte E; Benedetti MD; Capobussi M; Castellini G; Frau S; Gonzalez-Lorenzo M; Featherstone R; Filippini G
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012186. PubMed ID: 38032059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.